日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Administration of anti-HIV-1 broadly neutralizing monoclonal antibodies with increased affinity to Fcγ receptors during acute SHIVAD8-EO infection

在急性SHIVAD8-EO感染期间,使用对Fcγ受体具有更高亲和力的广谱中和抗HIV-1单克隆抗体进行治疗。

Joana Dias,Giulia Fabozzi,Slim Fourati,Xuejun Chen,Cuiping Liu,David R Ambrozak,Amy Ransier,Farida Laboune,Jianfei Hu,Wei Shi,Kylie March,Anna A Maximova,Stephen D Schmidt,Jakob Samsel,Chloe A Talana,Keenan Ernste,Sung Hee Ko,Margaret E Lucas,Pierce E Radecki,Kristin L Boswell,Yoshiaki Nishimura,John-Paul Todd,Malcolm A Martin,Constantinos Petrovas,Eli A Boritz,Nicole A Doria-Rose,Daniel C Douek,Rafick-Pierre Sékaly,Jeffrey D Lifson,Mangaiarkarasi Asokan,Lucio Gama,John R Mascola,Amarendra Pegu,Richard A Koup

NKTR-214 immunotherapy synergizes with radiotherapy to stimulate systemic CD8(+) T cell responses capable of curing multi-focal cancer.

NKTR-214 免疫疗法与放射疗法协同作用,刺激全身 CD8(+) T 细胞反应,从而治愈多灶性癌症

Walker Joshua M, Rolig Annah S, Charych Deborah H, Hoch Ute, Kasiewicz Melissa J, Rose Daniel C, McNamara Michael J, Hilgart-Martiszus Ian F, Redmond William L